Bio-Techne Acquires CyVek for $95,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f584170a-0520-440a-bb9d-f2f23ac0f3c6 - Date
11/4/2014 - Company Name
CyVek - Mailing Address
2 Barnes Industrial Road South Wallingford, CT 06492 USA - Company Description
The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation. - Website
http://www.cyvek.com - Transaction Type
M&A - Transaction Amount
$95,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.
